u/cryptarsh

Most WHM research has focused on healthy people. The immune modulation findings from the 2014 PNAS study are compelling, but what about people dealing with active cancer and elevated chronic inflammation? That question hasn't been rigorously studied yet.

A team led by Sara Matijevic, PhD at Oxford is running a 16-week feasibility pilot to find out. Physician-gated, preregistered, fully open-access. Wim Hof himself is a special advisor on the study.

I'm sharing this because I work with ResearchHub Foundation, which is hosting the proposal, and this community felt like the right place to bring it. The study is peer-reviewed and open for community crowdfunding.

Checkout the full proposal here: https://www.researchhub.com/proposal/4459/researchhub-proposal-wim-hof-method-whm-cold-exposure-for-cancer-instructor-guided-citizen-pilot

Some of you are already running BPC-157, GH secretagogues, or some version of a nootropic stack. The anecdotal evidence is everywhere. The peer-reviewed data is almost nowhere.

That's the actual problem. Not whether these compounds work - plenty of people believe they do - but that rigorous, reproducible, open-access science barely exists for most of them. Without it, dosing is guesswork, mechanisms are unclear, and the gray market keeps operating in a vacuum.

Brian Armstrong flagged this directly. He listed next-gen human enhancement across muscle, cognition, and mood as one of the most underinvested areas in frontier biology: https://x.com/brian_armstrong/status/2040479960683417804?s=20

ResearchHub Foundation took that seriously and opened two funding opportunities for researchers ready to generate real data.

Peptides for Human Health: rigorous research into peptide therapeutics across metabolism, tissue repair, neuroregeneration, aging, and body composition. BPC-157, TB-500, GLP-1 agonists, growth hormone secretagogues, and beyond.
Next-Gen Human Enhancement - Muscle, Cognition, and Mood: for researchers going beyond GLP-1s into myostatin inhibitors, BDNF mimetics, psychoplastogens, mitochondrial enhancers like MOTS-c and urolithin A, and gut-brain modulators.

Both are fully open-access and open to crowdfunding. Proposals are already coming in. Everything gets published regardless of outcome.

If you're a researcher or know one working in this space, this is worth sharing!

Oxford researchers want to study whether the Wim Hof Method can reduce inflammation in cancer patients

Brian Armstrong called peptides and next-gen human enhancement underinvested areas in biology. Let's get the science to catch up with the hype